Upstream / Downstream

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
Cytochrome c (D18C7) Rabbit mAb 11940 40 µl
Western Blotting Immunohistochemistry
H M R Mk 14 Rabbit IgG
Smac/Diablo Mouse mAb 2954 40 µl
Western Blotting Immunoprecipitation Immunohistochemistry Immunofluorescence
H Mk 21 Mouse IgG
HtrA2/Omi (D20A5) Rabbit mAb 9745 40 µl
Western Blotting
H M R Mk 36 Rabbit IgG
Caspase-3 (8G10) Rabbit mAb 9665 40 µl
Western Blotting Immunoprecipitation
H M R Mk 17, 19, 35 Rabbit IgG
Cox IV (4D11-B3-E8) Mouse mAb 11967 40 µl
Western Blotting Immunoprecipitation Immunohistochemistry Immunofluorescence
H M R Mk 17 Mouse IgG1
MEK1/2 (D1A5) Rabbit mAb 8727 40 µl
Western Blotting Immunofluorescence Flow Cytometry
H M R Mk Dm 45 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 
Anti-mouse IgG, HRP-linked Antibody 7076 100 µl
Western Blotting
All Horse 

Product Description

The Apoptotic Release Antibody Sampler Kit provides an economical means to evaluate targets that are released from the mitochondria with apoptotic stimuli. The kit contains enough primary antibody to perform four western blots per primary antibody.


Specificity / Sensitivity

Caspase-3 (8G10) Rabbit mAb recognizes endogenous levels of full-length (35 kDa) and large fragment (17/19 kDa) caspase-3 protein resulting from cleavage at Asp175. Cox IV (4D11-B3-E8) Mouse mAb recognizes endogenous levels of total Cox IV protein. Cytochrome c (D18C7) Rabbit mAb recognizes endogenous levels of total cytochrome c protein. HtrA2/Omi (D20A5) Rabbit mAb recognizes endogenous levels of total HtrA2/Omi protein and does not cross-react with HtrA1. MEK1/2 (D1A5) Rabbit mAb recognizes endogenous levels of total MEK1 and MEK2 proteins. This antibody is predicted to cross-react with MEK1/MEK2 orthologs in a variety of species. Smac/Diablo Mouse mAb recognizes endogenous levels of processed and unprocessed human Smac/Diablo protein and reacts weakly with mouse and rat Smac/Diablo.

Each antibody in the kit has been validated using the Cell Fractionation Kit #9038.


Source / Purification

Monoclonal antibodies are produced by immunizing animals with a full-length peptide corresponding to human Smac/Diablo protein raised in E. coli, or with synthetic peptides corresponding to amino-terminal residues adjacent to Asp175 of human caspase-3 protein, residues near the carboxy terminus of human Cox IV protein, residues surrounding Pro72 of human cytochrome c protein, residues surrounding Phe341 of human HtrA2/Omi protein, or residues surrounding Ala220 of human MEK1 protein.

Apoptosis is a regulated physiological process leading to cell death. Caspases, a family of cysteine acid proteases, are central regulators of apoptosis. Initiator caspases (including 8, 9, 10, and 12) are closely coupled to proapoptotic signals. Once activated, these caspases cleave and activate downstream effector caspases (including 3, 6, and 7), which in turn cleave cytoskeletal and nuclear proteins like PARP, α-fodrin, DFF, and lamin A, and induce apoptosis (1).

Cytochrome c is a well conserved electron-transport protein and is part of the respiratory chain localized to the mitochondrial intermembrane space (2). Upon apoptotic stimulation, cytochrome c released from mitochondria associates with procaspase-9 (47 kDa)/Apaf-1. This complex processes caspase-9 from inactive proenzyme to its active form (3). This event further triggers caspase-3 activation and eventually leads to apoptosis (4).

Smac/Diablo is a 21 kDa mammalian mitochondrial protein that functions as a regulatory component during apoptosis (5,6). Upon mitochondrial stress, Smac/Diablo is released from mitochondria and competes with caspases for binding of inhibitor of apoptosis proteins (IAPs) (5,6). The interaction of Smac/Diablo with IAPs relieves the inhibitory effect of the IAPs on caspases (7,8).

High temperature requirement protein A2 (HtrA2)/Omi is a serine protease with homology to the E. coli HtrA protein (DegP) and is thought to be involved in apoptosis and stress-induced degradation of misfolded proteins (9). HtrA2 is produced as a 50 kDa zymogen that is cleaved to generate a 36 kDa mature protein that exposes an amino terminal motif (AVPS) resembling that of the IAP inhibitor Smac/Diablo (10-14). Like Smac, interaction between HtrA2 and IAP family members, such as XIAP, antagonizes their inhibition of caspase activity and protection from apoptosis (10-14).

Caspase-3 (CPP-32, Apoptain, Yama, SCA-1) is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins, such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (15). Activation of caspase-3 requires proteolytic processing of its inactive zymogen into activated p17 and p12 fragments. Cleavage of caspase-3 requires the aspartic acid residue at the P1 position (16).

Cytochrome c oxidase (COX) is a hetero-oligomeric enzyme consisting of 13 subunits localized to the inner mitochondrial membrane (17-19). It is the terminal enzyme complex in the respiratory chain, catalyzing the reduction of molecular oxygen to water coupled to the translocation of protons across the mitochondrial inner membrane to drive ATP synthesis. The 3 largest subunits forming the catalytic core are encoded by mitochondrial DNA, while the other smaller subunits, including COX IV, are nuclear-encoded. The Cox IV (4D11-B3-E8) Mouse mAb can be used effectively as a mitochondrial loading control in cell-based research assays.

MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (20-22). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines, as well as by membrane depolarization and calcium influx (20-23). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII. The MEK1/2 (D1A5) Rabbit mAb can be used effectively as a cytoplasmic loading control in cell-based research assays.


1.  Budihardjo, I. et al. (1999) Annu Rev Cell Dev Biol 15, 269-90.

2.  Schagger H.H. et al. (2002) Biochem. Biophys. Acta. 1555, 154-159.

3.  Gray, C.W. et al. (2000) Eur. J. Biochem. 267, 5699-5710.

4.  Fernandes-Alnemri, T. et al. (1994) J Biol Chem 269, 30761-4.

5.  Ostermeier, C. et al. (1996) Curr. Opin. Struct. Biol. 6, 460-466.

6.  Crews, C.M. et al. (1992) Science 258, 478-480.

7.  Li, P. et al. (1997) Cell 91, 479-489.

8.  Nicholson, D.W. et al. (1995) Nature 376, 37-43.

9.  Capaldi, R.A. et al. (1983) Biochim. Biophys. Acta 726, 135-148.

10.  Alessi, D.R. et al. (1994) EMBO J. 13, 1610-1619.

11.  Liu, X. et al. (1996) Cell 86, 147-157.

12.  Suzuki, Y. et al. (2001) Mol. Cell 8, 613-621.

13.  Kadenbach, B. et al. (2000) Free Radic. Biol. Med. 29, 211-221.

14.  Rosen, L.B. et al. (1994) Neuron 12, 1207-1221.

15.  Hegde, R. et al. (2002) J. Biol. Chem. 277, 432-438.

16.  Cowley, S. et al. (1994) Cell 77, 841-852.

17.  Du, C. et al. (2000) Cell 102, 33-42.

18.  Verhagen, A.M. et al. (2000) Cell 102, 43-53.

19.  van Loo, G. et al. (2002) Cell Death Differ. 9, 20-26.

20.  Srinivasula, S.M. et al. (2001) Nature 410, 112-6.

21.  Verhagen, A.M. et al. (2002) J. Biol. Chem. 277, 445-454.

22.  Srinivasula, S.M. et al. (2000) J Biol Chem 275, 36152-7.

23.  Martins, L.M. et al. (2002) J. Biol. Chem. 277, 439-444.


Entrez-Gene Id 836, 1327, 54205, 56616, 27429, 5604, 5605
Swiss-Prot Acc. P42574, P13073, P99999, Q9NR28, O43464, Q02750, P36507


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.